Animal model of human hematopoietic tumor

Multicellular living organisms and unmodified parts thereof and – Method of making a transgenic nonhuman animal

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C800S003000, C800S008000, C435S325000

Reexamination Certificate

active

10533796

ABSTRACT:
Production and utilization of model mouse, in which human hematopoietic tumor cells can be grown, expressing symptom of human hematopoietic tumor, and can be used in the screening of anticancer drugs for human hematopoietic tumor.The invention provides a new method to produce model mouse for human hematopoietic tumor, including engraftment of human hematopoietic tumor cells into NOG (NOD/Shi-scid, IL-2Rγ KO) mice.

REFERENCES:
patent: 2003/0182671 (2003-09-01), Ito et al.
patent: WO 02/43477 (2002-06-01), None
Blase et al. (1995) Int. J. Cancer 60: 860-865.
Mitsuyoshi Urashima, et al., “The Development of a Model for the Homing of Multiple Myeloma Cells to Human Bone Marrow”, BLOOD, American Society of Hematology, vol. 90, No. 2 Jul. 15, 1997; pp. 754-765.
Yoshi Miyakawa, et al., “Establishment of Human Multiple Myeloma Model Using Newly Developed Immunodeficienent NOD/SCID./IL-2Rγ-/- (NOG) Mice”, Abstract #2366, Poster Board #-Session 650-II, American Society of Hematology, vol. 100, No. 11 Nov. 16, 2002; pp. 601a.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Animal model of human hematopoietic tumor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Animal model of human hematopoietic tumor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Animal model of human hematopoietic tumor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3871674

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.